Kokoh Exa Nusantara Tbk vs Merck Tbk. — how do they compare? Kokoh Exa Nusantara Tbk trades at Rp101 (market cap 451.21B, 14.06M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 3.8× Kokoh Exa Nusantara Tbk's market cap, and Kokoh Exa Nusantara Tbk is more actively traded (14.06M versus 37.6K). Which is the better fit depends on your goals.
| KOCI | MERK | |
|---|---|---|
Market Cap | 451.21B | 1.7T |
Volume | 14.06M | 37.6K |
Lot | 140.63K | 376 |
Turnover | 1.41B | 144.47M |
Average Price | 100.56 | 3,842.23 |
Value | 1.41B | 144.47M |
Indicative Equilibrium Price | 101 | 3,840 |
Indicative Equilibrium Volume | 1.94K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.
Read more on KOCI →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →